Global Gene Therapies for Cancer Treatment Market Research Report 2026(Status and Outlook)
Cancer gene therapy is an innovative treatment approach that involves directly modifying the patient's genome to treat cancer. Common strategies include Chimeric Antigen Receptor T-cell (CAR-T) therapy, gene editing technologies such as CRISPR-Cas9, and viral vector-mediated gene transduction. Compared to traditional chemotherapy and radiotherapy, gene therapies offer higher specificity and personalized advantages by repairing or replacing oncogenes at the molecular level, activating the immune system to recognize and eliminate tumor cells, or enhancing anti-tumor immune responses. Cancer gene therapies are applicable to various cancer types, including hematologic malignancies (such as leukemia and lymphoma) and solid tumors (such as lung and breast cancer). Although challenges remain, such as high costs, manufacturing complexities, and long-term efficacy, the demonstrated effectiveness in clinical trials positions gene therapy as a significant research direction in oncology.The cancer gene therapy market is rapidly evolving, driven by several key factors: First, the rising incidence of cancer and the limitations of traditional treatments have increased the demand for novel therapeutic options. Second, advancements in gene editing and cell engineering technologies have made the development and production of cancer gene therapies more feasible. Third, supportive policies from regulatory agencies regarding personalized and precision medicine have created a favorable environment for the clinical application of gene therapies. Fourth, patients' focus on efficacy and quality of life has driven the demand for innovative treatments. Additionally, collaborations between biopharmaceutical companies and research institutions have accelerated the translation of technologies and product development.Despite the significant potential of cancer gene therapies, several challenges and risks persist. First, the high treatment costs, involving personalized cell processing and gene editing, increase the burden on patients and healthcare systems. Second, the manufacturing process is complex, encompassing cell collection, gene modification, expansion, and reinfusion, with any deviation potentially impacting efficacy and safety. Third, the long-term efficacy and potential side effects are not yet fully understood, requiring more clinical data for validation. Fourth, the regulatory approval processes are cumbersome and time-consuming, potentially delaying the market introduction of new therapies. Fifth, the market is highly competitive, with numerous companies and research institutions investing in R&D, leading to increased risks of technological and product homogeneity.Downstream demand for cancer gene therapies is exhibiting the following trends: First, with the widespread adoption of precision medicine concepts, there is an increasing demand from patients and healthcare institutions for personalized treatment plans. Second, as efficacy data accumulates, more cancer patients, especially those with refractory or relapsed conditions, are considering gene therapies. Third, insurance companies and payers are gradually expanding coverage for gene therapies, reducing the financial burden on patients. Fourth, patients' concerns about treatment safety and quality of life are prompting research and development to focus more on controlling side effects and optimizing treatment regimens. Additionally, improvements in patient education and information access have enhanced acceptance of new therapies.
The global Gene Therapies for Cancer Treatment market size was estimated at USD 8230.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 18.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapies for Cancer Treatment market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapies for Cancer Treatment market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapies for Cancer Treatment market.
Global Gene Therapies for Cancer Treatment Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Biogen
Novartis
Gilead Sciences
SareptaTherapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Vectors
Non-viral Vectors
Market Segmentation (by Application)
Solid Tumors
Hematologic Malignancies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapies for Cancer Treatment Market
Overview of the regional outlook of the Gene Therapies for Cancer Treatment Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapies for Cancer Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapies for Cancer Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Gene Therapies for Cancer Treatment market size was estimated at USD 8230.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 18.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapies for Cancer Treatment market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapies for Cancer Treatment market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapies for Cancer Treatment market.
Global Gene Therapies for Cancer Treatment Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Biogen
Novartis
Gilead Sciences
SareptaTherapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Vectors
Non-viral Vectors
Market Segmentation (by Application)
Solid Tumors
Hematologic Malignancies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapies for Cancer Treatment Market
Overview of the regional outlook of the Gene Therapies for Cancer Treatment Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapies for Cancer Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapies for Cancer Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Therapies for Cancer Treatment
1.2 Key Market Segments
1.2.1 Gene Therapies for Cancer Treatment Segment by Type
1.2.2 Gene Therapies for Cancer Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPIES FOR CANCER TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapies for Cancer Treatment Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Therapies for Cancer Treatment Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPIES FOR CANCER TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapies for Cancer Treatment Product Life Cycle
3.3 Global Gene Therapies for Cancer Treatment Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapies for Cancer Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapies for Cancer Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapies for Cancer Treatment Market Competitive Situation and Trends
3.8.1 Gene Therapies for Cancer Treatment Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapies for Cancer Treatment Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPIES FOR CANCER TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapies for Cancer Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPIES FOR CANCER TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapies for Cancer Treatment Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapies for Cancer Treatment Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPIES FOR CANCER TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapies for Cancer Treatment Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapies for Cancer Treatment Market Size by Type (2020-2025)
6.4 Global Gene Therapies for Cancer Treatment Price by Type (2020-2025)
7 GENE THERAPIES FOR CANCER TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapies for Cancer Treatment Market Sales by Application (2020-2025)
7.3 Global Gene Therapies for Cancer Treatment Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapies for Cancer Treatment Sales Growth Rate by Application (2020-2025)
8 GENE THERAPIES FOR CANCER TREATMENT MARKET SALES BY REGION
8.1 Global Gene Therapies for Cancer Treatment Sales by Region
8.1.1 Global Gene Therapies for Cancer Treatment Sales by Region
8.1.2 Global Gene Therapies for Cancer Treatment Sales Market Share by Region
8.2 Global Gene Therapies for Cancer Treatment Market Size by Region
8.2.1 Global Gene Therapies for Cancer Treatment Market Size by Region
8.2.2 Global Gene Therapies for Cancer Treatment Market Size by Region
8.3 North America
8.3.1 North America Gene Therapies for Cancer Treatment Sales by Country
8.3.2 North America Gene Therapies for Cancer Treatment Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapies for Cancer Treatment Sales by Country
8.4.2 Europe Gene Therapies for Cancer Treatment Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapies for Cancer Treatment Sales by Region
8.5.2 Asia Pacific Gene Therapies for Cancer Treatment Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapies for Cancer Treatment Sales by Country
8.6.2 South America Gene Therapies for Cancer Treatment Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapies for Cancer Treatment Sales by Region
8.7.2 Middle East and Africa Gene Therapies for Cancer Treatment Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPIES FOR CANCER TREATMENT MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapies for Cancer Treatment by Region(2020-2025)
9.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapies for Cancer Treatment Production
9.4.1 North America Gene Therapies for Cancer Treatment Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapies for Cancer Treatment Production
9.5.1 Europe Gene Therapies for Cancer Treatment Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapies for Cancer Treatment Production (2020-2025)
9.6.1 Japan Gene Therapies for Cancer Treatment Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapies for Cancer Treatment Production (2020-2025)
9.7.1 China Gene Therapies for Cancer Treatment Production Growth Rate (2020-2025)
9.7.2 China Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Basic Information
10.1.2 Biogen Gene Therapies for Cancer Treatment Product Overview
10.1.3 Biogen Gene Therapies for Cancer Treatment Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Gene Therapies for Cancer Treatment Product Overview
10.2.3 Novartis Gene Therapies for Cancer Treatment Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Basic Information
10.3.2 Gilead Sciences Gene Therapies for Cancer Treatment Product Overview
10.3.3 Gilead Sciences Gene Therapies for Cancer Treatment Product Market Performance
10.3.4 Gilead Sciences Business Overview
10.3.5 Gilead Sciences SWOT Analysis
10.3.6 Gilead Sciences Recent Developments
10.4 SareptaTherapeutics
10.4.1 SareptaTherapeutics Basic Information
10.4.2 SareptaTherapeutics Gene Therapies for Cancer Treatment Product Overview
10.4.3 SareptaTherapeutics Gene Therapies for Cancer Treatment Product Market Performance
10.4.4 SareptaTherapeutics Business Overview
10.4.5 SareptaTherapeutics Recent Developments
10.5 Sunway Biotech
10.5.1 Sunway Biotech Basic Information
10.5.2 Sunway Biotech Gene Therapies for Cancer Treatment Product Overview
10.5.3 Sunway Biotech Gene Therapies for Cancer Treatment Product Market Performance
10.5.4 Sunway Biotech Business Overview
10.5.5 Sunway Biotech Recent Developments
10.6 SIBIONO
10.6.1 SIBIONO Basic Information
10.6.2 SIBIONO Gene Therapies for Cancer Treatment Product Overview
10.6.3 SIBIONO Gene Therapies for Cancer Treatment Product Market Performance
10.6.4 SIBIONO Business Overview
10.6.5 SIBIONO Recent Developments
10.7 AnGes
10.7.1 AnGes Basic Information
10.7.2 AnGes Gene Therapies for Cancer Treatment Product Overview
10.7.3 AnGes Gene Therapies for Cancer Treatment Product Market Performance
10.7.4 AnGes Business Overview
10.7.5 AnGes Recent Developments
10.8 Orchard Therapeutics
10.8.1 Orchard Therapeutics Basic Information
10.8.2 Orchard Therapeutics Gene Therapies for Cancer Treatment Product Overview
10.8.3 Orchard Therapeutics Gene Therapies for Cancer Treatment Product Market Performance
10.8.4 Orchard Therapeutics Business Overview
10.8.5 Orchard Therapeutics Recent Developments
10.9 Human Stem Cells Institute
10.9.1 Human Stem Cells Institute Basic Information
10.9.2 Human Stem Cells Institute Gene Therapies for Cancer Treatment Product Overview
10.9.3 Human Stem Cells Institute Gene Therapies for Cancer Treatment Product Market Performance
10.9.4 Human Stem Cells Institute Business Overview
10.9.5 Human Stem Cells Institute Recent Developments
11 GENE THERAPIES FOR CANCER TREATMENT MARKET FORECAST BY REGION
11.1 Global Gene Therapies for Cancer Treatment Market Size Forecast
11.2 Global Gene Therapies for Cancer Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapies for Cancer Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapies for Cancer Treatment Market Size Forecast by Region
11.2.4 South America Gene Therapies for Cancer Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapies for Cancer Treatment by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Therapies for Cancer Treatment Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Therapies for Cancer Treatment by Type (2026-2035)
12.1.2 Global Gene Therapies for Cancer Treatment Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Therapies for Cancer Treatment by Type (2026-2035)
12.2 Global Gene Therapies for Cancer Treatment Market Forecast by Application (2026-2035)
12.2.1 Global Gene Therapies for Cancer Treatment Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapies for Cancer Treatment Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Therapies for Cancer Treatment
1.2 Key Market Segments
1.2.1 Gene Therapies for Cancer Treatment Segment by Type
1.2.2 Gene Therapies for Cancer Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPIES FOR CANCER TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapies for Cancer Treatment Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gene Therapies for Cancer Treatment Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPIES FOR CANCER TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapies for Cancer Treatment Product Life Cycle
3.3 Global Gene Therapies for Cancer Treatment Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapies for Cancer Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapies for Cancer Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapies for Cancer Treatment Market Competitive Situation and Trends
3.8.1 Gene Therapies for Cancer Treatment Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapies for Cancer Treatment Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPIES FOR CANCER TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapies for Cancer Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPIES FOR CANCER TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapies for Cancer Treatment Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapies for Cancer Treatment Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPIES FOR CANCER TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapies for Cancer Treatment Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapies for Cancer Treatment Market Size by Type (2020-2025)
6.4 Global Gene Therapies for Cancer Treatment Price by Type (2020-2025)
7 GENE THERAPIES FOR CANCER TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapies for Cancer Treatment Market Sales by Application (2020-2025)
7.3 Global Gene Therapies for Cancer Treatment Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapies for Cancer Treatment Sales Growth Rate by Application (2020-2025)
8 GENE THERAPIES FOR CANCER TREATMENT MARKET SALES BY REGION
8.1 Global Gene Therapies for Cancer Treatment Sales by Region
8.1.1 Global Gene Therapies for Cancer Treatment Sales by Region
8.1.2 Global Gene Therapies for Cancer Treatment Sales Market Share by Region
8.2 Global Gene Therapies for Cancer Treatment Market Size by Region
8.2.1 Global Gene Therapies for Cancer Treatment Market Size by Region
8.2.2 Global Gene Therapies for Cancer Treatment Market Size by Region
8.3 North America
8.3.1 North America Gene Therapies for Cancer Treatment Sales by Country
8.3.2 North America Gene Therapies for Cancer Treatment Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapies for Cancer Treatment Sales by Country
8.4.2 Europe Gene Therapies for Cancer Treatment Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapies for Cancer Treatment Sales by Region
8.5.2 Asia Pacific Gene Therapies for Cancer Treatment Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapies for Cancer Treatment Sales by Country
8.6.2 South America Gene Therapies for Cancer Treatment Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapies for Cancer Treatment Sales by Region
8.7.2 Middle East and Africa Gene Therapies for Cancer Treatment Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPIES FOR CANCER TREATMENT MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapies for Cancer Treatment by Region(2020-2025)
9.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapies for Cancer Treatment Production
9.4.1 North America Gene Therapies for Cancer Treatment Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapies for Cancer Treatment Production
9.5.1 Europe Gene Therapies for Cancer Treatment Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapies for Cancer Treatment Production (2020-2025)
9.6.1 Japan Gene Therapies for Cancer Treatment Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapies for Cancer Treatment Production (2020-2025)
9.7.1 China Gene Therapies for Cancer Treatment Production Growth Rate (2020-2025)
9.7.2 China Gene Therapies for Cancer Treatment Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Basic Information
10.1.2 Biogen Gene Therapies for Cancer Treatment Product Overview
10.1.3 Biogen Gene Therapies for Cancer Treatment Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Gene Therapies for Cancer Treatment Product Overview
10.2.3 Novartis Gene Therapies for Cancer Treatment Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Basic Information
10.3.2 Gilead Sciences Gene Therapies for Cancer Treatment Product Overview
10.3.3 Gilead Sciences Gene Therapies for Cancer Treatment Product Market Performance
10.3.4 Gilead Sciences Business Overview
10.3.5 Gilead Sciences SWOT Analysis
10.3.6 Gilead Sciences Recent Developments
10.4 SareptaTherapeutics
10.4.1 SareptaTherapeutics Basic Information
10.4.2 SareptaTherapeutics Gene Therapies for Cancer Treatment Product Overview
10.4.3 SareptaTherapeutics Gene Therapies for Cancer Treatment Product Market Performance
10.4.4 SareptaTherapeutics Business Overview
10.4.5 SareptaTherapeutics Recent Developments
10.5 Sunway Biotech
10.5.1 Sunway Biotech Basic Information
10.5.2 Sunway Biotech Gene Therapies for Cancer Treatment Product Overview
10.5.3 Sunway Biotech Gene Therapies for Cancer Treatment Product Market Performance
10.5.4 Sunway Biotech Business Overview
10.5.5 Sunway Biotech Recent Developments
10.6 SIBIONO
10.6.1 SIBIONO Basic Information
10.6.2 SIBIONO Gene Therapies for Cancer Treatment Product Overview
10.6.3 SIBIONO Gene Therapies for Cancer Treatment Product Market Performance
10.6.4 SIBIONO Business Overview
10.6.5 SIBIONO Recent Developments
10.7 AnGes
10.7.1 AnGes Basic Information
10.7.2 AnGes Gene Therapies for Cancer Treatment Product Overview
10.7.3 AnGes Gene Therapies for Cancer Treatment Product Market Performance
10.7.4 AnGes Business Overview
10.7.5 AnGes Recent Developments
10.8 Orchard Therapeutics
10.8.1 Orchard Therapeutics Basic Information
10.8.2 Orchard Therapeutics Gene Therapies for Cancer Treatment Product Overview
10.8.3 Orchard Therapeutics Gene Therapies for Cancer Treatment Product Market Performance
10.8.4 Orchard Therapeutics Business Overview
10.8.5 Orchard Therapeutics Recent Developments
10.9 Human Stem Cells Institute
10.9.1 Human Stem Cells Institute Basic Information
10.9.2 Human Stem Cells Institute Gene Therapies for Cancer Treatment Product Overview
10.9.3 Human Stem Cells Institute Gene Therapies for Cancer Treatment Product Market Performance
10.9.4 Human Stem Cells Institute Business Overview
10.9.5 Human Stem Cells Institute Recent Developments
11 GENE THERAPIES FOR CANCER TREATMENT MARKET FORECAST BY REGION
11.1 Global Gene Therapies for Cancer Treatment Market Size Forecast
11.2 Global Gene Therapies for Cancer Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapies for Cancer Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapies for Cancer Treatment Market Size Forecast by Region
11.2.4 South America Gene Therapies for Cancer Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapies for Cancer Treatment by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gene Therapies for Cancer Treatment Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gene Therapies for Cancer Treatment by Type (2026-2035)
12.1.2 Global Gene Therapies for Cancer Treatment Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gene Therapies for Cancer Treatment by Type (2026-2035)
12.2 Global Gene Therapies for Cancer Treatment Market Forecast by Application (2026-2035)
12.2.1 Global Gene Therapies for Cancer Treatment Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapies for Cancer Treatment Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapies for Cancer Treatment Market Size by Type (M USD)
Table 4. Global Gene Therapies for Cancer Treatment Market Size by Application
Table 5. Gene Therapies for Cancer Treatment Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapies for Cancer Treatment Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gene Therapies for Cancer Treatment Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapies for Cancer Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapies for Cancer Treatment Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2025)
Table 11. Global Market Gene Therapies for Cancer Treatment Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gene Therapies for Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapies for Cancer Treatment Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Therapies for Cancer Treatment Sales by Type (K Units)
Table 27. Global Gene Therapies for Cancer Treatment Market Size by Type (M USD)
Table 28. Global Gene Therapies for Cancer Treatment Sales (K Units) by Type (2020-2025)
Table 29. Global Gene Therapies for Cancer Treatment Sales Market Share by Type (2020-2025)
Table 30. Global Gene Therapies for Cancer Treatment Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Therapies for Cancer Treatment Market Share by Type (2020-2025)
Table 32. Global Gene Therapies for Cancer Treatment Price (USD/Unit) by Type (2020-2025)
Table 33. Global Gene Therapies for Cancer Treatment Sales (K Units) by Application
Table 34. Global Gene Therapies for Cancer Treatment Market Size by Application
Table 35. Global Gene Therapies for Cancer Treatment Sales by Application (2020-2025) & (K Units)
Table 36. Global Gene Therapies for Cancer Treatment Sales Market Share by Application (2020-2025)
Table 37. Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Therapies for Cancer Treatment Market Share by Application (2020-2025)
Table 39. Global Gene Therapies for Cancer Treatment Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Therapies for Cancer Treatment Sales by Region (2020-2025) & (K Units)
Table 41. Global Gene Therapies for Cancer Treatment Sales Market Share by Region (2020-2025)
Table 42. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025)
Table 44. North America Gene Therapies for Cancer Treatment Sales by Country (2020-2025) & (K Units)
Table 45. North America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Therapies for Cancer Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Europe Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Therapies for Cancer Treatment Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Therapies for Cancer Treatment Sales by Country (2020-2025) & (K Units)
Table 51. South America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Therapies for Cancer Treatment Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Therapies for Cancer Treatment Production (K Units) by Region(2020-2025)
Table 55. Global Gene Therapies for Cancer Treatment Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Therapies for Cancer Treatment Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Biogen Basic Information
Table 63. Biogen Gene Therapies for Cancer Treatment Product Overview
Table 64. Biogen Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Biogen Business Overview
Table 66. Biogen SWOT Analysis
Table 67. Biogen Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Gene Therapies for Cancer Treatment Product Overview
Table 70. Novartis Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Gilead Sciences Basic Information
Table 75. Gilead Sciences Gene Therapies for Cancer Treatment Product Overview
Table 76. Gilead Sciences Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences SWOT Analysis
Table 79. Gilead Sciences Recent Developments
Table 80. SareptaTherapeutics Basic Information
Table 81. SareptaTherapeutics Gene Therapies for Cancer Treatment Product Overview
Table 82. SareptaTherapeutics Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. SareptaTherapeutics Business Overview
Table 84. SareptaTherapeutics Recent Developments
Table 85. Sunway Biotech Basic Information
Table 86. Sunway Biotech Gene Therapies for Cancer Treatment Product Overview
Table 87. Sunway Biotech Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Sunway Biotech Business Overview
Table 89. Sunway Biotech Recent Developments
Table 90. SIBIONO Basic Information
Table 91. SIBIONO Gene Therapies for Cancer Treatment Product Overview
Table 92. SIBIONO Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. SIBIONO Business Overview
Table 94. SIBIONO Recent Developments
Table 95. AnGes Basic Information
Table 96. AnGes Gene Therapies for Cancer Treatment Product Overview
Table 97. AnGes Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. AnGes Business Overview
Table 99. AnGes Recent Developments
Table 100. Orchard Therapeutics Basic Information
Table 101. Orchard Therapeutics Gene Therapies for Cancer Treatment Product Overview
Table 102. Orchard Therapeutics Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Orchard Therapeutics Business Overview
Table 104. Orchard Therapeutics Recent Developments
Table 105. Human Stem Cells Institute Basic Information
Table 106. Human Stem Cells Institute Gene Therapies for Cancer Treatment Product Overview
Table 107. Human Stem Cells Institute Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Human Stem Cells Institute Business Overview
Table 109. Human Stem Cells Institute Recent Developments
Table 110. Global Gene Therapies for Cancer Treatment Sales Forecast by Region (2026-2035) & (K Units)
Table 111. Global Gene Therapies for Cancer Treatment Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Gene Therapies for Cancer Treatment Sales Forecast by Country (2026-2035) & (K Units)
Table 113. North America Gene Therapies for Cancer Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Gene Therapies for Cancer Treatment Sales Forecast by Country (2026-2035) & (K Units)
Table 115. Europe Gene Therapies for Cancer Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Gene Therapies for Cancer Treatment Sales Forecast by Region (2026-2035) & (K Units)
Table 117. Asia Pacific Gene Therapies for Cancer Treatment Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Gene Therapies for Cancer Treatment Sales Forecast by Country (2026-2035) & (K Units)
Table 119. South America Gene Therapies for Cancer Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Gene Therapies for Cancer Treatment Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Gene Therapies for Cancer Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Gene Therapies for Cancer Treatment Sales Forecast by Type (2026-2035) & (K Units)
Table 123. Global Gene Therapies for Cancer Treatment Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Gene Therapies for Cancer Treatment Price Forecast by Type (2026-2035) & (USD/Unit)
Table 125. Global Gene Therapies for Cancer Treatment Sales (K Units) Forecast by Application (2026-2035)
Table 126. Global Gene Therapies for Cancer Treatment Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gene Therapies for Cancer Treatment Market Size by Type (M USD)
Table 4. Global Gene Therapies for Cancer Treatment Market Size by Application
Table 5. Gene Therapies for Cancer Treatment Market Size Comparison by Region (M USD)
Table 6. Global Gene Therapies for Cancer Treatment Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Gene Therapies for Cancer Treatment Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gene Therapies for Cancer Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gene Therapies for Cancer Treatment Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2025)
Table 11. Global Market Gene Therapies for Cancer Treatment Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gene Therapies for Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapies for Cancer Treatment Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gene Therapies for Cancer Treatment Sales by Type (K Units)
Table 27. Global Gene Therapies for Cancer Treatment Market Size by Type (M USD)
Table 28. Global Gene Therapies for Cancer Treatment Sales (K Units) by Type (2020-2025)
Table 29. Global Gene Therapies for Cancer Treatment Sales Market Share by Type (2020-2025)
Table 30. Global Gene Therapies for Cancer Treatment Market Size (M USD) by Type (2020-2025)
Table 31. Global Gene Therapies for Cancer Treatment Market Share by Type (2020-2025)
Table 32. Global Gene Therapies for Cancer Treatment Price (USD/Unit) by Type (2020-2025)
Table 33. Global Gene Therapies for Cancer Treatment Sales (K Units) by Application
Table 34. Global Gene Therapies for Cancer Treatment Market Size by Application
Table 35. Global Gene Therapies for Cancer Treatment Sales by Application (2020-2025) & (K Units)
Table 36. Global Gene Therapies for Cancer Treatment Sales Market Share by Application (2020-2025)
Table 37. Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gene Therapies for Cancer Treatment Market Share by Application (2020-2025)
Table 39. Global Gene Therapies for Cancer Treatment Sales Growth Rate by Application (2020-2025)
Table 40. Global Gene Therapies for Cancer Treatment Sales by Region (2020-2025) & (K Units)
Table 41. Global Gene Therapies for Cancer Treatment Sales Market Share by Region (2020-2025)
Table 42. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025)
Table 44. North America Gene Therapies for Cancer Treatment Sales by Country (2020-2025) & (K Units)
Table 45. North America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gene Therapies for Cancer Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Europe Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gene Therapies for Cancer Treatment Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gene Therapies for Cancer Treatment Sales by Country (2020-2025) & (K Units)
Table 51. South America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gene Therapies for Cancer Treatment Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gene Therapies for Cancer Treatment Production (K Units) by Region(2020-2025)
Table 55. Global Gene Therapies for Cancer Treatment Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gene Therapies for Cancer Treatment Revenue Market Share by Region (2020-2025)
Table 57. Global Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Gene Therapies for Cancer Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Biogen Basic Information
Table 63. Biogen Gene Therapies for Cancer Treatment Product Overview
Table 64. Biogen Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Biogen Business Overview
Table 66. Biogen SWOT Analysis
Table 67. Biogen Recent Developments
Table 68. Novartis Basic Information
Table 69. Novartis Gene Therapies for Cancer Treatment Product Overview
Table 70. Novartis Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Novartis Business Overview
Table 72. Novartis SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Gilead Sciences Basic Information
Table 75. Gilead Sciences Gene Therapies for Cancer Treatment Product Overview
Table 76. Gilead Sciences Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences SWOT Analysis
Table 79. Gilead Sciences Recent Developments
Table 80. SareptaTherapeutics Basic Information
Table 81. SareptaTherapeutics Gene Therapies for Cancer Treatment Product Overview
Table 82. SareptaTherapeutics Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. SareptaTherapeutics Business Overview
Table 84. SareptaTherapeutics Recent Developments
Table 85. Sunway Biotech Basic Information
Table 86. Sunway Biotech Gene Therapies for Cancer Treatment Product Overview
Table 87. Sunway Biotech Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Sunway Biotech Business Overview
Table 89. Sunway Biotech Recent Developments
Table 90. SIBIONO Basic Information
Table 91. SIBIONO Gene Therapies for Cancer Treatment Product Overview
Table 92. SIBIONO Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. SIBIONO Business Overview
Table 94. SIBIONO Recent Developments
Table 95. AnGes Basic Information
Table 96. AnGes Gene Therapies for Cancer Treatment Product Overview
Table 97. AnGes Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. AnGes Business Overview
Table 99. AnGes Recent Developments
Table 100. Orchard Therapeutics Basic Information
Table 101. Orchard Therapeutics Gene Therapies for Cancer Treatment Product Overview
Table 102. Orchard Therapeutics Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Orchard Therapeutics Business Overview
Table 104. Orchard Therapeutics Recent Developments
Table 105. Human Stem Cells Institute Basic Information
Table 106. Human Stem Cells Institute Gene Therapies for Cancer Treatment Product Overview
Table 107. Human Stem Cells Institute Gene Therapies for Cancer Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Human Stem Cells Institute Business Overview
Table 109. Human Stem Cells Institute Recent Developments
Table 110. Global Gene Therapies for Cancer Treatment Sales Forecast by Region (2026-2035) & (K Units)
Table 111. Global Gene Therapies for Cancer Treatment Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Gene Therapies for Cancer Treatment Sales Forecast by Country (2026-2035) & (K Units)
Table 113. North America Gene Therapies for Cancer Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Gene Therapies for Cancer Treatment Sales Forecast by Country (2026-2035) & (K Units)
Table 115. Europe Gene Therapies for Cancer Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Gene Therapies for Cancer Treatment Sales Forecast by Region (2026-2035) & (K Units)
Table 117. Asia Pacific Gene Therapies for Cancer Treatment Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Gene Therapies for Cancer Treatment Sales Forecast by Country (2026-2035) & (K Units)
Table 119. South America Gene Therapies for Cancer Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Gene Therapies for Cancer Treatment Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Gene Therapies for Cancer Treatment Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Gene Therapies for Cancer Treatment Sales Forecast by Type (2026-2035) & (K Units)
Table 123. Global Gene Therapies for Cancer Treatment Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Gene Therapies for Cancer Treatment Price Forecast by Type (2026-2035) & (USD/Unit)
Table 125. Global Gene Therapies for Cancer Treatment Sales (K Units) Forecast by Application (2026-2035)
Table 126. Global Gene Therapies for Cancer Treatment Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Therapies for Cancer Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapies for Cancer Treatment Market Size (M USD), 2025-2035
Figure 5. Global Gene Therapies for Cancer Treatment Market Size (M USD) (2020-2035)
Figure 6. Global Gene Therapies for Cancer Treatment Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapies for Cancer Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapies for Cancer Treatment Product Life Cycle
Figure 13. Gene Therapies for Cancer Treatment Sales Share by Manufacturers in 2025
Figure 14. Global Gene Therapies for Cancer Treatment Revenue Share by Manufacturers in 2025
Figure 15. Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Therapies for Cancer Treatment Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapies for Cancer Treatment Revenue in 2025
Figure 18. Industry Chain Map of Gene Therapies for Cancer Treatment
Figure 19. Global Gene Therapies for Cancer Treatment Market PEST Analysis
Figure 20. Global Gene Therapies for Cancer Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapies for Cancer Treatment Market Share by Type
Figure 27. Sales Market Share of Gene Therapies for Cancer Treatment by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapies for Cancer Treatment by Type in 2025
Figure 29. Market Share of Gene Therapies for Cancer Treatment by Type (2020-2025)
Figure 30. Market Share of Gene Therapies for Cancer Treatment by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapies for Cancer Treatment Market Share by Application
Figure 33. Global Gene Therapies for Cancer Treatment Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapies for Cancer Treatment Sales Market Share by Application in 2025
Figure 35. Global Gene Therapies for Cancer Treatment Market Share by Application (2020-2025)
Figure 36. Global Gene Therapies for Cancer Treatment Market Share by Application in 2025
Figure 37. Global Gene Therapies for Cancer Treatment Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapies for Cancer Treatment Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025)
Figure 40. North America Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapies for Cancer Treatment Sales Market Share by Country in 2024
Figure 43. North America Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapies for Cancer Treatment Market Size by Country in 2024
Figure 45. U.S. Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapies for Cancer Treatment Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapies for Cancer Treatment Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapies for Cancer Treatment Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapies for Cancer Treatment Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapies for Cancer Treatment Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapies for Cancer Treatment Market Size by Country in 2024
Figure 55. Germany Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapies for Cancer Treatment Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapies for Cancer Treatment Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapies for Cancer Treatment Market Size by Region in 2024
Figure 68. China Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapies for Cancer Treatment Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapies for Cancer Treatment Sales Market Share by Country in 2024
Figure 80. South America Gene Therapies for Cancer Treatment Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapies for Cancer Treatment Market Size by Country in 2024
Figure 82. Brazil Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapies for Cancer Treatment Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapies for Cancer Treatment Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapies for Cancer Treatment Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapies for Cancer Treatment Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapies for Cancer Treatment Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapies for Cancer Treatment Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapies for Cancer Treatment Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapies for Cancer Treatment Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapies for Cancer Treatment Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapies for Cancer Treatment Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Gene Therapies for Cancer Treatment Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Therapies for Cancer Treatment Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Therapies for Cancer Treatment Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Therapies for Cancer Treatment Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Therapies for Cancer Treatment Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gene Therapies for Cancer Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapies for Cancer Treatment Market Size (M USD), 2025-2035
Figure 5. Global Gene Therapies for Cancer Treatment Market Size (M USD) (2020-2035)
Figure 6. Global Gene Therapies for Cancer Treatment Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapies for Cancer Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapies for Cancer Treatment Product Life Cycle
Figure 13. Gene Therapies for Cancer Treatment Sales Share by Manufacturers in 2025
Figure 14. Global Gene Therapies for Cancer Treatment Revenue Share by Manufacturers in 2025
Figure 15. Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gene Therapies for Cancer Treatment Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapies for Cancer Treatment Revenue in 2025
Figure 18. Industry Chain Map of Gene Therapies for Cancer Treatment
Figure 19. Global Gene Therapies for Cancer Treatment Market PEST Analysis
Figure 20. Global Gene Therapies for Cancer Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapies for Cancer Treatment Market Share by Type
Figure 27. Sales Market Share of Gene Therapies for Cancer Treatment by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapies for Cancer Treatment by Type in 2025
Figure 29. Market Share of Gene Therapies for Cancer Treatment by Type (2020-2025)
Figure 30. Market Share of Gene Therapies for Cancer Treatment by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapies for Cancer Treatment Market Share by Application
Figure 33. Global Gene Therapies for Cancer Treatment Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapies for Cancer Treatment Sales Market Share by Application in 2025
Figure 35. Global Gene Therapies for Cancer Treatment Market Share by Application (2020-2025)
Figure 36. Global Gene Therapies for Cancer Treatment Market Share by Application in 2025
Figure 37. Global Gene Therapies for Cancer Treatment Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapies for Cancer Treatment Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025)
Figure 40. North America Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapies for Cancer Treatment Sales Market Share by Country in 2024
Figure 43. North America Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapies for Cancer Treatment Market Size by Country in 2024
Figure 45. U.S. Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapies for Cancer Treatment Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapies for Cancer Treatment Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapies for Cancer Treatment Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapies for Cancer Treatment Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapies for Cancer Treatment Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapies for Cancer Treatment Market Size by Country in 2024
Figure 55. Germany Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapies for Cancer Treatment Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapies for Cancer Treatment Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapies for Cancer Treatment Market Size by Region in 2024
Figure 68. China Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapies for Cancer Treatment Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapies for Cancer Treatment Sales Market Share by Country in 2024
Figure 80. South America Gene Therapies for Cancer Treatment Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapies for Cancer Treatment Market Size by Country in 2024
Figure 82. Brazil Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapies for Cancer Treatment Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapies for Cancer Treatment Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapies for Cancer Treatment Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapies for Cancer Treatment Market Size by Region in 2024
Figure 92. Saudi Arabia Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapies for Cancer Treatment Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapies for Cancer Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapies for Cancer Treatment Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapies for Cancer Treatment Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapies for Cancer Treatment Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapies for Cancer Treatment Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapies for Cancer Treatment Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapies for Cancer Treatment Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Gene Therapies for Cancer Treatment Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gene Therapies for Cancer Treatment Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gene Therapies for Cancer Treatment Market Share Forecast by Type (2026-2035)
Figure 111. Global Gene Therapies for Cancer Treatment Sales Forecast by Application (2026-2035)
Figure 112. Global Gene Therapies for Cancer Treatment Market Share Forecast by Application (2026-2035)
